Role of integrin expression in the prediction of response to vedolizumab : a prospective real‐life multicentre cohort study
- Author
- Cara De Galan, Bryan Gonzales (UGent) , Sophie Van Welden (UGent) , Simon Tavernier (UGent) , Triana Lobatón Ortega (UGent) , Wouter Van Moerkercke, Beatrijs Strubbe, Harald Peeters, Elisabeth Macken, Martine De Vos (UGent) , Debby Laukens (UGent) and Pieter Hindryckx (UGent)
- Organization
- Keywords
- Molecular Medicine, Medicine (miscellaneous)
Downloads
-
4735 22DeGalan.pdf
- full text (Published version)
- |
- open access
- |
- |
- 708.60 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8749077
- MLA
- De Galan, Cara, et al. “Role of Integrin Expression in the Prediction of Response to Vedolizumab : A Prospective Real‐life Multicentre Cohort Study.” CLINICAL AND TRANSLATIONAL MEDICINE, vol. 12, no. 4, 2022, doi:10.1002/ctm2.769.
- APA
- De Galan, C., Gonzales, B., Van Welden, S., Tavernier, S., Lobatón Ortega, T., Van Moerkercke, W., … Hindryckx, P. (2022). Role of integrin expression in the prediction of response to vedolizumab : a prospective real‐life multicentre cohort study. CLINICAL AND TRANSLATIONAL MEDICINE, 12(4). https://doi.org/10.1002/ctm2.769
- Chicago author-date
- De Galan, Cara, Bryan Gonzales, Sophie Van Welden, Simon Tavernier, Triana Lobatón Ortega, Wouter Van Moerkercke, Beatrijs Strubbe, et al. 2022. “Role of Integrin Expression in the Prediction of Response to Vedolizumab : A Prospective Real‐life Multicentre Cohort Study.” CLINICAL AND TRANSLATIONAL MEDICINE 12 (4). https://doi.org/10.1002/ctm2.769.
- Chicago author-date (all authors)
- De Galan, Cara, Bryan Gonzales, Sophie Van Welden, Simon Tavernier, Triana Lobatón Ortega, Wouter Van Moerkercke, Beatrijs Strubbe, Harald Peeters, Elisabeth Macken, Martine De Vos, Debby Laukens, and Pieter Hindryckx. 2022. “Role of Integrin Expression in the Prediction of Response to Vedolizumab : A Prospective Real‐life Multicentre Cohort Study.” CLINICAL AND TRANSLATIONAL MEDICINE 12 (4). doi:10.1002/ctm2.769.
- Vancouver
- 1.De Galan C, Gonzales B, Van Welden S, Tavernier S, Lobatón Ortega T, Van Moerkercke W, et al. Role of integrin expression in the prediction of response to vedolizumab : a prospective real‐life multicentre cohort study. CLINICAL AND TRANSLATIONAL MEDICINE. 2022;12(4).
- IEEE
- [1]C. De Galan et al., “Role of integrin expression in the prediction of response to vedolizumab : a prospective real‐life multicentre cohort study,” CLINICAL AND TRANSLATIONAL MEDICINE, vol. 12, no. 4, 2022.
@article{8749077,
articleno = {{e769}},
author = {{De Galan, Cara and Gonzales, Bryan and Van Welden, Sophie and Tavernier, Simon and Lobatón Ortega, Triana and Van Moerkercke, Wouter and Strubbe, Beatrijs and Peeters, Harald and Macken, Elisabeth and De Vos, Martine and Laukens, Debby and Hindryckx, Pieter}},
issn = {{2001-1326}},
journal = {{CLINICAL AND TRANSLATIONAL MEDICINE}},
keywords = {{Molecular Medicine,Medicine (miscellaneous)}},
language = {{eng}},
number = {{4}},
pages = {{5}},
title = {{Role of integrin expression in the prediction of response to vedolizumab : a prospective real‐life multicentre cohort study}},
url = {{http://doi.org/10.1002/ctm2.769}},
volume = {{12}},
year = {{2022}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: